Vermillion private placement comes through

Vermillion ($VRML) said it has raised a net of just under $12 million through a previously announced private placement. The Texas-based molecular diagnostics company also issued warrants that could boost that number another $18.3 million if and when the warrants are exercised. Plans call for using the money to boost sales of the company's diagnostics tests and increase development of next-generation ovarian cancer diagnostics tests. The funding will also help fuel efforts to improve the reimbursement environment for OVA1, the company's flagship ovarian cancer diagnostic test. Release

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.